Goldman Sachs’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-27,700
Closed -$221K 7673
2015
Q1
$221K Buy
27,700
+8,400
+44% +$58.9K ﹤0.01% 5937
2014
Q4
$109K Sell
19,300
-27,900
-59% -$150K ﹤0.01% 6545
2014
Q3
$233K Buy
47,200
+5,100
+12% +$27.6K ﹤0.01% 6020
2014
Q2
$240K Buy
42,100
+26,800
+175% +$160K ﹤0.01% 6055
2014
Q1
$113K Buy
15,300
+2,900
+23% +$21.3K ﹤0.01% 6359
2013
Q4
$89K Sell
12,400
-45,700
-79% -$339K ﹤0.01% 6316
2013
Q3
$451K Sell
58,100
-42,100
-42% -$327K ﹤0.01% 5229
2013
Q2
$653K Buy
+100,200
New +$630K ﹤0.01% 4730

Goldman Sachs's ELX Position: Q2 2015 in Review

Goldman Sachs sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 72,569 shares — an estimated $578K sold.

Goldman Sachs first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $8.26M in Q2 2014. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Goldman Sachs reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Goldman Sachs sold 72,569 EMULEX CORP shares in Q2 2015, an estimated $578K.
  • Goldman Sachs first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Goldman Sachs's EMULEX CORP position peaked at $8.26M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.